The COVIDTrach prospective cohort study on outcomes in 1982 tracheostomised COVID-19 patients during the first and second UK pandemic waves
Abstract COVIDTrach is a UK-wide, prospective cohort study evaluating tracheostomised COVID-19 patient outcomes and operator disease transmission. Early in the pandemic controversy surrounded optimal timing of tracheostomy insertion, however meta-analyses have since addressed this uncertainty. We re...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-93391-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849402589426221056 |
|---|---|
| author | Matthew Haywood Gareth Ambler Ciara Walker Asit Arora Tony Jacob Anne G. M. Schilder Nick Hamilton COVIDTrach Collaborators |
| author_facet | Matthew Haywood Gareth Ambler Ciara Walker Asit Arora Tony Jacob Anne G. M. Schilder Nick Hamilton COVIDTrach Collaborators |
| author_sort | Matthew Haywood |
| collection | DOAJ |
| description | Abstract COVIDTrach is a UK-wide, prospective cohort study evaluating tracheostomised COVID-19 patient outcomes and operator disease transmission. Early in the pandemic controversy surrounded optimal timing of tracheostomy insertion, however meta-analyses have since addressed this uncertainty. We report on our cohort’s data and outcomes to help inform the management of this disease and compare our findings to the literature. Our inclusion criteria were COVID-19 patients aged ≥ 18 undergoing tracheostomy following invasive ventilation. We recorded relevant characteristics, clinical parameters, intra-operative details and outcome data. Predictors for mortality and time to ventilatory wean were determined. Among 1982 patients, there was a 21% post-tracheostomy mortality and median intubation to tracheostomy time of 15 days (IQR 11–21). The median time to successful ventilatory wean post-tracheostomy was 12 days (IQR 7–20). Advancing age, greater FiO2 and PEEP requirements and inotrope or anticoagulant use were associated with increased mortality (p < 0.05) and time to wean success (p < 0.01). Higher CRP predicted increased mortality (p < 0.05), while NIV use and extended pre-tracheostomy ventilation predicted prolonged wean time (p < 0.01). The death risk for tracheostomy performed ≤ 7 or ≥ 14 days of ventilation was equivocal (OR 1.01, 95% CI [0.37–2.72]) but lower between 8 and 14 days (OR = 0.64, 95% CI [0.47–0.86]) (p = 0.01). Eight operators tested positive within two weeks of performing a tracheostomy. Our mortality rates were similar to cohort studies but lower than early versus late tracheostomy designs. In contrast to the literature, we found reduced mortality when tracheostomy was performed 8–14 days post-intubation, with more favourable wean time and wean and decannulation rates. |
| format | Article |
| id | doaj-art-ff41762b00444f8fa53d4e78466328ef |
| institution | Kabale University |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-ff41762b00444f8fa53d4e78466328ef2025-08-20T03:37:30ZengNature PortfolioScientific Reports2045-23222025-07-0115111210.1038/s41598-025-93391-wThe COVIDTrach prospective cohort study on outcomes in 1982 tracheostomised COVID-19 patients during the first and second UK pandemic wavesMatthew Haywood0Gareth Ambler1Ciara Walker2Asit Arora3Tony Jacob4Anne G. M. Schilder5Nick Hamilton6COVIDTrach CollaboratorsRoyal National Ear Nose and Throat and Eastman Dental Hospitals, University College London Hospitals NHS Foundation TrustDepartment of Statistical Science, University College LondonRoyal National Ear Nose and Throat and Eastman Dental Hospitals, University College London Hospitals NHS Foundation TrustGuy’s and St Thomas’ NHS Foundation TrustUniversity Hospital LewishamRoyal National Ear Nose and Throat and Eastman Dental Hospitals, University College London Hospitals NHS Foundation TrustRoyal National Ear Nose and Throat and Eastman Dental Hospitals, University College London Hospitals NHS Foundation TrustAbstract COVIDTrach is a UK-wide, prospective cohort study evaluating tracheostomised COVID-19 patient outcomes and operator disease transmission. Early in the pandemic controversy surrounded optimal timing of tracheostomy insertion, however meta-analyses have since addressed this uncertainty. We report on our cohort’s data and outcomes to help inform the management of this disease and compare our findings to the literature. Our inclusion criteria were COVID-19 patients aged ≥ 18 undergoing tracheostomy following invasive ventilation. We recorded relevant characteristics, clinical parameters, intra-operative details and outcome data. Predictors for mortality and time to ventilatory wean were determined. Among 1982 patients, there was a 21% post-tracheostomy mortality and median intubation to tracheostomy time of 15 days (IQR 11–21). The median time to successful ventilatory wean post-tracheostomy was 12 days (IQR 7–20). Advancing age, greater FiO2 and PEEP requirements and inotrope or anticoagulant use were associated with increased mortality (p < 0.05) and time to wean success (p < 0.01). Higher CRP predicted increased mortality (p < 0.05), while NIV use and extended pre-tracheostomy ventilation predicted prolonged wean time (p < 0.01). The death risk for tracheostomy performed ≤ 7 or ≥ 14 days of ventilation was equivocal (OR 1.01, 95% CI [0.37–2.72]) but lower between 8 and 14 days (OR = 0.64, 95% CI [0.47–0.86]) (p = 0.01). Eight operators tested positive within two weeks of performing a tracheostomy. Our mortality rates were similar to cohort studies but lower than early versus late tracheostomy designs. In contrast to the literature, we found reduced mortality when tracheostomy was performed 8–14 days post-intubation, with more favourable wean time and wean and decannulation rates.https://doi.org/10.1038/s41598-025-93391-wCOVID-19Noninvasive ventilationIntubationTracheostomyVentilator weaningPandemic |
| spellingShingle | Matthew Haywood Gareth Ambler Ciara Walker Asit Arora Tony Jacob Anne G. M. Schilder Nick Hamilton COVIDTrach Collaborators The COVIDTrach prospective cohort study on outcomes in 1982 tracheostomised COVID-19 patients during the first and second UK pandemic waves Scientific Reports COVID-19 Noninvasive ventilation Intubation Tracheostomy Ventilator weaning Pandemic |
| title | The COVIDTrach prospective cohort study on outcomes in 1982 tracheostomised COVID-19 patients during the first and second UK pandemic waves |
| title_full | The COVIDTrach prospective cohort study on outcomes in 1982 tracheostomised COVID-19 patients during the first and second UK pandemic waves |
| title_fullStr | The COVIDTrach prospective cohort study on outcomes in 1982 tracheostomised COVID-19 patients during the first and second UK pandemic waves |
| title_full_unstemmed | The COVIDTrach prospective cohort study on outcomes in 1982 tracheostomised COVID-19 patients during the first and second UK pandemic waves |
| title_short | The COVIDTrach prospective cohort study on outcomes in 1982 tracheostomised COVID-19 patients during the first and second UK pandemic waves |
| title_sort | covidtrach prospective cohort study on outcomes in 1982 tracheostomised covid 19 patients during the first and second uk pandemic waves |
| topic | COVID-19 Noninvasive ventilation Intubation Tracheostomy Ventilator weaning Pandemic |
| url | https://doi.org/10.1038/s41598-025-93391-w |
| work_keys_str_mv | AT matthewhaywood thecovidtrachprospectivecohortstudyonoutcomesin1982tracheostomisedcovid19patientsduringthefirstandsecondukpandemicwaves AT garethambler thecovidtrachprospectivecohortstudyonoutcomesin1982tracheostomisedcovid19patientsduringthefirstandsecondukpandemicwaves AT ciarawalker thecovidtrachprospectivecohortstudyonoutcomesin1982tracheostomisedcovid19patientsduringthefirstandsecondukpandemicwaves AT asitarora thecovidtrachprospectivecohortstudyonoutcomesin1982tracheostomisedcovid19patientsduringthefirstandsecondukpandemicwaves AT tonyjacob thecovidtrachprospectivecohortstudyonoutcomesin1982tracheostomisedcovid19patientsduringthefirstandsecondukpandemicwaves AT annegmschilder thecovidtrachprospectivecohortstudyonoutcomesin1982tracheostomisedcovid19patientsduringthefirstandsecondukpandemicwaves AT nickhamilton thecovidtrachprospectivecohortstudyonoutcomesin1982tracheostomisedcovid19patientsduringthefirstandsecondukpandemicwaves AT covidtrachcollaborators thecovidtrachprospectivecohortstudyonoutcomesin1982tracheostomisedcovid19patientsduringthefirstandsecondukpandemicwaves AT matthewhaywood covidtrachprospectivecohortstudyonoutcomesin1982tracheostomisedcovid19patientsduringthefirstandsecondukpandemicwaves AT garethambler covidtrachprospectivecohortstudyonoutcomesin1982tracheostomisedcovid19patientsduringthefirstandsecondukpandemicwaves AT ciarawalker covidtrachprospectivecohortstudyonoutcomesin1982tracheostomisedcovid19patientsduringthefirstandsecondukpandemicwaves AT asitarora covidtrachprospectivecohortstudyonoutcomesin1982tracheostomisedcovid19patientsduringthefirstandsecondukpandemicwaves AT tonyjacob covidtrachprospectivecohortstudyonoutcomesin1982tracheostomisedcovid19patientsduringthefirstandsecondukpandemicwaves AT annegmschilder covidtrachprospectivecohortstudyonoutcomesin1982tracheostomisedcovid19patientsduringthefirstandsecondukpandemicwaves AT nickhamilton covidtrachprospectivecohortstudyonoutcomesin1982tracheostomisedcovid19patientsduringthefirstandsecondukpandemicwaves AT covidtrachcollaborators covidtrachprospectivecohortstudyonoutcomesin1982tracheostomisedcovid19patientsduringthefirstandsecondukpandemicwaves |